Research
+2

Mar 27, 2026
•
13 min read
Two large randomised trials and mounting real-world evidence suggest a cheap diabetes drug could cut the risk of long COVID. But the story is more complicated than the headlines suggest.


Subscribe to Therapy Insights for practical tips, expert advice, and the latest solutions to enhance your independence and well-being with personalised therapy insights!